🔴 Gyre Therapeutics is trading 5.3% down today as Treasury yields hit highs unseen since 2007

Gyre Therapeutics is trading 5.3% down at $7.01 as biotechnology and growth stocks weaken amid a broader risk-off session.

• The 10-year Treasury yield reached its highest level since 2007.
• Elevated oil prices and persistent inflation concerns increased fears of prolonged restrictive interest rates.
• No company-specific announcement, regulatory action, earnings release, or analyst event was identified for September 24, 2026.